DE69601116D1 - Verfahren zur Herstellung von (s)-Beta-hydroxy-gamma-butirolactone - Google Patents

Verfahren zur Herstellung von (s)-Beta-hydroxy-gamma-butirolactone

Info

Publication number
DE69601116D1
DE69601116D1 DE69601116T DE69601116T DE69601116D1 DE 69601116 D1 DE69601116 D1 DE 69601116D1 DE 69601116 T DE69601116 T DE 69601116T DE 69601116 T DE69601116 T DE 69601116T DE 69601116 D1 DE69601116 D1 DE 69601116D1
Authority
DE
Germany
Prior art keywords
gamma
beta
hydroxy
butirolactone
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69601116T
Other languages
English (en)
Other versions
DE69601116T2 (de
Inventor
Fabio Giannessi
Angelis Francesco De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE69601116D1 publication Critical patent/DE69601116D1/de
Publication of DE69601116T2 publication Critical patent/DE69601116T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Seasonings (AREA)
DE69601116T 1995-09-29 1996-07-18 Verfahren zur Herstellung von (s)-Beta-hydroxy-gamma-butirolactone Expired - Fee Related DE69601116T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000652A IT1276207B1 (it) 1995-09-29 1995-09-29 Procedimento per la preparazione del (s)-b-idrossi-gamma- butirrolattone

Publications (2)

Publication Number Publication Date
DE69601116D1 true DE69601116D1 (de) 1999-01-21
DE69601116T2 DE69601116T2 (de) 1999-05-06

Family

ID=11403592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69601116T Expired - Fee Related DE69601116T2 (de) 1995-09-29 1996-07-18 Verfahren zur Herstellung von (s)-Beta-hydroxy-gamma-butirolactone

Country Status (12)

Country Link
US (1) US5714619A (de)
EP (1) EP0765876B1 (de)
JP (1) JP4012588B2 (de)
KR (1) KR100407645B1 (de)
AT (1) ATE174333T1 (de)
CA (1) CA2181012A1 (de)
DE (1) DE69601116T2 (de)
DK (1) DK0765876T3 (de)
ES (1) ES2126969T3 (de)
GR (1) GR3029537T3 (de)
IT (1) IT1276207B1 (de)
ZA (1) ZA968127B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1297120B1 (it) * 1997-12-16 1999-08-03 Sigma Tau Ind Farmaceuti Procedimento per la produzione di (r)-3-idrossi-4-butirrolattone utile nella preparazione della (r)-carnitina
EP1055654B1 (de) 1998-12-11 2008-02-20 Daicel Chemical Industries, Ltd. Verfahren zur herstellung von organischen verbindungen mit imid-katalysatoren
KR20000065995A (ko) * 1999-04-12 2000-11-15 박영구 키랄 3-히드록시-γ-부티로락톤의 제조방법
CN104961711B (zh) * 2015-07-23 2017-03-08 沧州那瑞化学科技有限公司 （s）‑3‑羟基四氢呋喃和（r）‑3‑羟基四氢呋喃的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3087325B2 (ja) * 1991-02-21 2000-09-11 チッソ株式会社 光学活性化合物とその製造法
IT1256705B (it) * 1992-12-21 1995-12-12 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.
IT1261230B (it) * 1993-04-08 1996-05-09 Sigma Tau Ind Farmaceuti Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione.
IT1261231B (it) * 1993-04-08 1996-05-09 Sigma Tau Ind Farmaceuti Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.
IT1261489B (it) * 1993-07-29 1996-05-23 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
US5473104A (en) * 1994-09-13 1995-12-05 Neurocrine Biosciences, Inc. Process for the preparation of L-carnitine

Also Published As

Publication number Publication date
ITRM950652A0 (de) 1995-09-29
DE69601116T2 (de) 1999-05-06
EP0765876A1 (de) 1997-04-02
ITRM950652A1 (it) 1997-03-29
ES2126969T3 (es) 1999-04-01
KR100407645B1 (ko) 2004-03-18
DK0765876T3 (da) 1999-08-16
GR3029537T3 (en) 1999-06-30
US5714619A (en) 1998-02-03
ATE174333T1 (de) 1998-12-15
CA2181012A1 (en) 1997-03-30
KR970015583A (ko) 1997-04-28
JP4012588B2 (ja) 2007-11-21
IT1276207B1 (it) 1997-10-27
EP0765876B1 (de) 1998-12-09
JPH09110851A (ja) 1997-04-28
ZA968127B (en) 1997-04-21

Similar Documents

Publication Publication Date Title
ATE359994T1 (de) Verfahren zur herstellung von oxazolidinonen
ATE121066T1 (de) Verfahren zur herstellung von 6,12-dihydro-6- hydroxy-cannabidiol und dessen anwendung zur herstellung von trans-delta-9- tetrahydrocannabinol.
ATE153332T1 (de) Verfahren zur herstellung von oxetanonen
DE69716713D1 (de) Verfahren zur herstellung von d-threo-(r,r)-methylphenidat und recycling nicht erwünschter enantiomere durch epimerisierung
DE69705896T2 (de) Verfahren zur Herstellung amorphen Paroxetin-Hydrochlorids
ATE131474T1 (de) Verfahren zur herstellung cyclischer carbonate
DE59007171D1 (de) Verfahren zur herstellung von sclareolid.
ATE204283T1 (de) Verfahren zur herstellung von 2,2- difluorketensilylacetalen und alpha,alpha-difluor-beta -silyloxy-1,3-dioxolan-4-propansäureestern
DE69601116D1 (de) Verfahren zur Herstellung von (s)-Beta-hydroxy-gamma-butirolactone
DE69010405D1 (de) Verfahren zur Herstellung von R(+)-Aminocarnitin und S(-)-Aminocarnitin.
ATE221876T1 (de) Verfahren zur herstellung von zyklischen verbindungen
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE130597T1 (de) Verfahren zur herstellung von r-aminocarnitin und s-aminocarnitin.
DE3855002D1 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
DE3764875D1 (de) Verfahren zur herstellung von penemderivaten.
ATE132535T1 (de) Verfahren zur diskontinuierlichen herstellung von l-carnitin auf mikrobiologischem weg
DE69010256D1 (de) Verfahren zur Herstellung von L-Ornithin durch Fermentation.
DE60106057D1 (de) Verfahren zur herstellung von baccatin iii-derivativen
ATE269863T1 (de) Verfahren zur herstellung von granisetron
ATE145641T1 (de) Verfahren zur herstellung von l-(-)-carnitin aus abfallprodukten mit entgegengesetzter konfiguration
DE69008487D1 (de) Verfahren zur Herstellung von Vinyl-GABA.
ATE133656T1 (de) Verfahren zur herstellung von 2-amino-5,6- dimethoxy tetralin
ATE236144T1 (de) Verfahren zur herstellung von (r)-3-hydroxy-4- butyrolacton, nützlich für die herstellung von (r)-carnitin
ATE117676T1 (de) Verfahren zur herstellung von molluskiziden 2,4,5-tribrompyrrol-3-carbonitrilen.
DE69930071D1 (de) Fermentations-Verfahren zur Herstellung von Erythritol mittels eines Mutanten von Candida sp. mit hoher Salztoleranz

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee